“We think the marketing opportunity here and execution opportunity here could be big, given that [Cologuard] tests are pretty good and we’ve got a lot of good feedback from physicians,” Tobin says.
(Don't worry. We don't bite)
Already a Hedgeye subscriber? Please log-in to your account.
Entering your email simply means you agree to receive special marketing email from Hedgeye.
That's it. You can unsubscribe whenever you like.